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The observation by Krehl, Teply, Sarma & Elvehjem (1945) that rats deficient in nicotinic acid would grow well if tryptophan was supplied elicited much interest, and a number of reports have appeared showing that tryptophan is the dietary precursor of nicotinic acid and its derivatives in the rat (Rosen, Huff & Perlzweig, 1946) , pig (Luecke, McMillen, Throp & Tull, 1947) , horse (Schweigert, Pearson & Wilkening, 1947) , dog (Singal, Sydenstricker & Littlejohn, 1948) and man (Sarett & Goldsmith, 1947) . It has also been established both in the rat (Heidelberger, 1949) and the Ascomycete fungus, Neuro8pora (Mitchell & Nyc, 1948) that tryptophan is converted into nicotinic acid through a series of intermediary substances, such as kynurenine, 3-hydroxykynurenine, and 3-hydroxyanthranilic acid.
Some of the vitamins of the B group influence the conversion of tryptophan into nicotinic acid. The investigations of Lepkovsky, Roboz & HaagenSmit (1943) , , Rosen, Huff & Perlzweig (1947) showed that pyridoxine has a role in the conversion of tryptophan into nicotinic acid in the rat, mice and swine. Junqueira & Schweigert (1948) noted reduced urinary excretion of nicotinic acid and N'-methylnicotinamide in rats deficient in thiamine, riboflavin, pyridoxine and pteroylglutamic acid. Porter, Clark & Silber (1948) showed that thiamine, riboflavin and pyridoxine also affect the excretion of kynurenine, kynurenic acid and xanthurenic acid. Henderson, Weinstock & Ramasarma (1951) reported that during riboflavin and pyridoxine deficiencies, the ability of the rat to convert tryptophan and kynurenine into quinolinic acid was markedly impaired. These deficiencies, however, had no effect on the conversion of 3-hydroxyanthranilic acid into quinolinic acid. Shanmuga Sundaram, Ranganathan & Sarma (1951) , using deoxypyridoxine, an antimetabolite of pyridoxine, showed that pyridoxine is involved in the biosynthesis of nicotinic acid in germinating pulses (Pha8eolu8 mungo).
The vitamin biotin (I) has been shown to be involved in amino acid oxidation (Lichstein & Umbreit, 1947; Thayer & Horowitz, 1951) , and since this process takes place in tryptophan metabolism (Daigliesh, 1951) it was thought that biotin might possibly have an influence in the metabolism of tryptophan as well. Further, Shanmuga Sundaram & Sarma (1954) undertaken to elucidate the role and site of action of biotin in the conversion of tryptophan and its metabolites into nicotinic acid. Moreover, it was found that by using mutant strains of Neurospora crassa unable to synthesize nicotinic acid on the basal medium, but which respond quantitatively to each of the metabolites formed during the course of the conversion of tryptophan into nicotinic acid, both the site of action of biotin and the amount of utilization of the various metabolites could be conveniently observed. y-(3:4-Ureylenecyctohexyl)-butyric acid was used as the antimetabolite of biotin in these studies.
EXPERIMENTAL
Organism and growth media. Two strains of N. crassa (39401 and 5029), obtained through the courtesy of Dr Herschel K. Mitchell, University of California, U.S.A., were used in the investigation. Strain 39401 is able to utilize all the metabolites of tryptophan for nicotinic acid synthesis, and the gene block is located at the precursor-indole linkage, as illustrated in the accompanying scheme. This strain is able to synthesize serine. gene block (39401) precursor indole -+ tryptophan kynurenine 4 *-gene block (5029) nicotinic 3-hydroxyanthranilic 3-hydroxykynurenine acid acid
Strain 5029, however, is not able to utilize either tryptophan or kynurenine, but is able to convert 3-hydroxykynurenine and 3-hydroxyanthranilic acid into nicotinic acid. Here the gene block is located at the kynurenine-*3-hydroxykynurenine linkage. The organisms were cultured as described by Horowitz & Beadle (1943) on Fries's medium which had the following composition (g./l.): ammonium tartarate, 5; NH4NO3, 1; K2HPO4, 1; NaCl, 0-1; MgSO4, 0-5; CaCl2, 0-1; D-glucose, 20; and the following trace elements, added as salts in mg./l.: B, 0-01; Mo, 0-02; Fe, 0-2; Cu, 0-1; Mn, 0-02 and Zn, 2-0. Biotin was added at a level of 5 pg./l. The pH of the medium largely depended upon the metabolite utilized by the organism. It was adjusted to 4-6 in the case of nicotinic acid and 3-hydroxyanthranilic acid, and to 5-6 in the case of tryptophan, formylkynurenine, kynurenine and 3-hydroxykynurenine. The media were dispensed in 10 ml. lots in 50 ml. conical flasks and sterilized at 15 lb. for 15 min. The inoculum was made by suspending washed spores from a 72 hr. old slant in sterile saline and adjusting the suspension to 80 % transmission in a photoelectric colorimeter; one drop of this suspension was added to each flask. Incubation was carried out at 28-30°for 72 hr. The mycelia were then collected, washed, partially dried on filter-paper folds and then dried to constant wt. in a vacuum desiccator. The dried mycelia were then accurately weighed in a RollerSmith Torsion balance.
The growth response of the two strains of N. crassa to the various metabolites ( Figs. 1 and 2) indicates that the optimum levels (in i&g.) of the metabolites for maximal growth are as follows: L-tryptophan, 200; DL-formyl-I954 kynurenine, 175; DL-kynurenine sulphate, 120; DL-3-hydroxykynurenine, 80; 3-hydroxyanthranilic acid, 25; nicotinic acid, 7-5. The influence of the antimetabolite of biotin, y-(3:4-ureylenecyclohexyl)butyric acid, on the utilization of the various metabolites for nicotinic acid synthesis by the organisms was studied with the metabolites added in such a manner as to promote maximal growth of the organisms, so that any decrease in growth would be due not to a partial deficiency with respect to the metabolite but only to an interference caused by the presence of the ureylene derivative (see Figs. 3 and 4 ).
--30 Table 1 with optimum pH 5-6. Table 1 with optimum pH 4-6.
In vitro 8tudies. The organism N. cras8a, grown on a medium containing L-tryptophan for 72 hr., was used. The wet mycelium was washed thoroughly and made into a uniform suspension in ice-cold O1M phosphate buffer (pH 6 8) using a Waring Blendor. A known volume of the suspension was added to (i) L-tryptophan, (ii) L-tryptophan with the ureylene compound and (iii) L-tryptophan, the ureylene compound and excess biotin. After 16 hr. incubation at 370, the reaction was stopped using trichloroacetic acid, and tryptophan in the solution was estimated immediately.
Estimation of tryptophan. Tryptophan in the incubated solution was estimated colorimetrically using the methods of Horn & Jones (1945) and Eckert (1943) .
RESULTS AND DISCUSSION
The results presented in Figs. 3 and 4 show that the antimetabolite of biotin only affects the utilization of tryptophan; the inhibition in utilization is overcome by biotin, as represented in Table 1 . As the ureylene compound has not any significant influence on the utilization of the other metabolites of tryptophan --nicotinic acid mechanism in the two strains of the fungus, it is evident that biotin has a role only in the conversion of tryptophan into the primary intermediate kynurenine.
In their preliminary work on the tryptophan kynurenine conversion, Knox, Mero, Grossman & Auerbach (1949) first showed that kynurenine formation from tryptophan in liver homogenates of rats is carried out only under aerobic conditions. Later, and found that tryptophan is converted by the supernatant liquid of a fresh liver homogenate into a diazotizable, aromatic amine, identified as formylkynurenine, with the uptake of one molecule of oxygen and simultaneous liberation of hydrogen peroxide. The formylkynurenine so formed is broken down by a second enzyme, called 'formylase' into kynurenine and formic acid. The first reaction, involving the formation of formylkynurenine from tryptophan, was shown by In all experiments, 9 mg. of L-tryptophan in 3 ml. water were treated with 4 ml. Neuro8pora suspension in buffer; 1 ml. suspension contained 12 mg. dry wt. To this medium additions were made as shown in column 1 and incubated for 16 hr. at 37°. The reaction was stopped by adding 1 ml. of 10% trichloroacetic acid and tryptophan was estimated immediately. The Since the ureylene derivative has no influence on the utilization of formylkynurenine, as may be observed from the figures, it is clear that biotin is involved in one or both of the enzyme systems, peroxidase or oxidase, which take part in the formation offormylkynurenine. Although the identity of the unknown intermediate A is open to question, Dalgliesh, Knox & Neuberger (1951) suggested that peroxide adds on to tryptophan to give 2:3-dihydro-2:3-dihydroxytryptophan, which by dehydrogenation with simultaneous ring opening could yield formylkynurenine. The verification of this attractive suggestion must necessarily await the isolation or the synthesis of the diol. The results obtained by incubating tryptophan with the mycelial suspension (Table 2) show that only about 6% of tryptophan is oxidized in presence of the ureylene compound compared with about 35 % in the control experiment. The addition of biotin completely eliminates the deleterious effect of the ureylene compound. The fact that tryptophan is apparently unchanged, as shown by the chemical estimation, indicates that biotin may influence the peroxidase step as it does the oxidative deamination of various amino acids in N. cra88a (Bender, Krebs & Horowitz, 1949; Burton, 1951; Siva Sankar, Tirunarayanan & Sarma, 1952) . However, the manner in which biotin influences the oxidation of tryptophan can be determined only after investigating whether there is any formation of an unknown intermediate compound with an absorption in the ultraviolet different from that of tryptophan and formylkynurenine or with different physical or chemical characteristics. Such a study is in progress. SUMMARY 1. y-(3:4-Ureylenecyclohexyl)butyric acid, an antimetabolite of biotin, inhibits the utilization of tryptophan by a nicotinic acid-requiring mutant of N. cra88a (39401) and this inhibition is overcome by the addition of biotin. This indicates that biotin is involved in the metabolism of tryptophan.
2. Biotin functions only in the tryptophan -+ formylkynurenine reaction and the utilization of formylkynurenine is not affected by biotin deficiency.
3. The ureylene derivative does not affect the utilization of other intermediates in the conversion of tryptophan into nicotinic acid such as formylkynurenine, kynurenine, 3-hydroxykynurenine, 3-hydroxyanthranilic acid and nicotinic acid.
4. In vitro studies with suspensions of Neurospora mycelia show an accumulation of tryptophan during biotin deficiency, and it is suggested that biotin may be involved in the formation of an unknown intermediate between tryptophan and formylkynurenine.
